Skip to main content

Table 3 Performance of four different tests for rivaroxaban monitoring (threshold: 30 ng/mL)

From: Comparison of different laboratory tests in the evaluation of hemorrhagic risk of patients using rivaroxaban in the critical care setting: diagnostic accuracy study

Test

Sensitivity (%, 95% CI)

Specificity (%, 95% CI)

PPV (%, 95% CI)

NPV (%, 95% CI)

PT

88 (74–96)

71 (54–85)

77 (67–85)

84 (70–93)

aPTT

67 (50–80)

71 (54–85)

72 (60–81)

66 (55–76)

dRVVs

100 (92–100)

16 (6–31)

57 (53–60)

100

dRVVc

100 (92–100)

24 (11–40)

59 (41–64)

100

  1. PPV positive predictive value, NPV negative predictive value, CI confidence interval
Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us